Drahoslava Pantoflickova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Drahoslava Pantoflickova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hans R. Koelz
Division of Gastroenterology, Department of Medicine, Triemli Hospital, Zurich, Switzerland
2 shared publications A L Blum
1 shared publicationA. L. Blum
Gastroenterology Department, CHUV, Lausanne, Switzerland
1 shared publicationAndrél. Blum
1 shared publicationG. Dorta
Gastroenterology Department, CHUV, Lausanne, Switzerland
1 shared publicationM. Ravic
Eisai Ltd, London, UK
1 shared publication
Latest Publications
- Open Access
- 20 June 2003
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (12) , 1507-1514
Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors
Summary: Background: Rapid and consistent acid suppression on the first day of dosing may be important in treating acid‐related disorders.Aim: To compare the antisecretory activity and onset of action of single doses of rabeprazole, lansoprazole, pantoprazole, omeprazole capsule, omeprazole multiple unit pellet system (MUPS) tablet and placebo in healthy Helicobacter pylori‐negative subjects.Methods: This cross‐over, double‐blind, randomized study was performed in 18 H. pylori‐negative subjects. Twenty‐four‐hour intragastric pH monitoring was performed on the day of treatment (once‐daily dose of rabeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, omeprazole capsule 20 mg, omeprazole MUPS tablet 20 mg or placebo).Results: The intragastric pH (3.4) and time at pH > 4 during the 24 h post‐dose (8.0 h) were significantly greater with rabeprazole than with lansoprazole, pantoprazole, omeprazole capsule, omeprazole MUPS tablet or placebo (P ≤ 0.04 for rabeprazole vs. the others). Daytime and night‐time pH values were higher with rabeprazole and lansoprazole than with pantoprazole, omeprazole capsule and omeprazole MUPS tablet (P ≤ 0.04).Conclusion: Rabeprazole was the most potent acid inhibitor of all the proton pump inhibitors tested during the first day of dosing.
- 20 June 2003
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (12) , 1507-1514
Open AccessAcid inhibition on the first day of dosing: comparison of four proton pump inhibitors
Summary: Background: Rapid and consistent acid suppression on the first day of dosing may be important in treating acid‐related disorders.Aim: To compare the antisecretory activity and onset of action of single doses of rabeprazole, lansoprazole, pantoprazole, omeprazole capsule, omeprazole multiple unit pellet system (MUPS) tablet and placebo in healthy Helicobacter pylori‐negative subjects.Methods: This cross‐over, double‐blind, randomized study was performed in 18 H. pylori‐negative subjects. Twenty‐four‐hour intragastric pH monitoring was performed on the day of treatment (once‐daily dose of rabeprazole 20 mg, lansoprazole 30 mg, pantoprazole 40 mg, omeprazole capsule 20 mg, omeprazole MUPS tablet 20 mg or placebo).Results: The intragastric pH (3.4) and time at pH > 4 during the 24 h post‐dose (8.0 h) were significantly greater with rabeprazole than with lansoprazole, pantoprazole, omeprazole capsule, omeprazole MUPS tablet or placebo (P ≤ 0.04 for rabeprazole vs. the others). Daytime and night‐time pH values were higher with rabeprazole and lansoprazole than with pantoprazole, omeprazole capsule and omeprazole MUPS tablet (P ≤ 0.04).Conclusion: Rabeprazole was the most potent acid inhibitor of all the proton pump inhibitors tested during the first day of dosing.
- 1 September 1998
- Published by Elsevier in Bailliere's Clinical Gastroenterology
- Vol. 12 (3) , 503-532
7 Helicobacter pylori and functional dyspepsia: a real causal link?
- 1 September 1998
- Published by Elsevier in Bailliere's Clinical Gastroenterology
- Vol. 12 (3) , 503-532
7 Helicobacter pylori and functional dyspepsia: a real causal link?